PROGYNY INC (PGNY) Stock Fundamental Analysis
USA - NASDAQ:PGNY - US74340E1038 - Common Stock
19.09 USD
-0.14 (-0.73%)
19.09 USD
0 (0%)
Taking everything into account, PGNY scores 6 out of 10 in our fundamental rating. PGNY was compared to 101 industry peers in the Health Care Providers & Services industry. PGNY gets an excellent profitability rating and is at the same time showing great financial health properties. PGNY has a decent growth rate and is not valued too expensively. With these ratings, PGNY could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
PGNY had positive earnings in the past year.
PGNY had a positive operating cash flow in the past year.
Each year in the past 5 years PGNY has been profitable.
In the past 5 years PGNY always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 6.98%, PGNY belongs to the best of the industry, outperforming 88.12% of the companies in the same industry.
PGNY has a Return On Equity of 10.31%. This is in the better half of the industry: PGNY outperforms 74.26% of its industry peers.
PGNY has a Return On Invested Capital of 10.87%. This is amongst the best in the industry. PGNY outperforms 82.18% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PGNY is in line with the industry average of 9.34%.
The 3 year average ROIC (8.25%) for PGNY is below the current ROIC(10.87%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 10.31% | ||
| ROIC | 10.87% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
1.3 Margins
With a decent Profit Margin value of 4.28%, PGNY is doing good in the industry, outperforming 75.25% of the companies in the same industry.
PGNY's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 6.18%, PGNY is doing good in the industry, outperforming 64.36% of the companies in the same industry.
In the last couple of years the Operating Margin of PGNY has grown nicely.
PGNY's Gross Margin of 22.34% is in line compared to the rest of the industry. PGNY outperforms 45.54% of its industry peers.
PGNY's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.18% | ||
| PM (TTM) | 4.28% | ||
| GM | 22.34% |
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PGNY is creating some value.
Compared to 1 year ago, PGNY has less shares outstanding
PGNY has more shares outstanding than it did 5 years ago.
PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 6.88 indicates that PGNY is not in any danger for bankruptcy at the moment.
PGNY has a Altman-Z score of 6.88. This is amongst the best in the industry. PGNY outperforms 91.09% of its industry peers.
PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 6.88 |
ROIC/WACC1.19
WACC9.15%
2.3 Liquidity
A Current Ratio of 2.70 indicates that PGNY has no problem at all paying its short term obligations.
The Current ratio of PGNY (2.70) is better than 83.17% of its industry peers.
A Quick Ratio of 2.70 indicates that PGNY has no problem at all paying its short term obligations.
PGNY has a better Quick ratio (2.70) than 83.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.7 | ||
| Quick Ratio | 2.7 |
3. Growth
3.1 Past
The earnings per share for PGNY have decreased by -6.35% in the last year.
PGNY shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.77% yearly.
PGNY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.62%.
Measured over the past years, PGNY shows a very strong growth in Revenue. The Revenue has been growing by 38.42% on average per year.
EPS 1Y (TTM)-6.35%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%11.76%
Revenue 1Y (TTM)9.62%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.47%
3.2 Future
Based on estimates for the next years, PGNY will show a very strong growth in Earnings Per Share. The EPS will grow by 32.47% on average per year.
The Revenue is expected to grow by 8.86% on average over the next years. This is quite good.
EPS Next Y10.72%
EPS Next 2Y34.66%
EPS Next 3Y31.82%
EPS Next 5Y32.47%
Revenue Next Year9.74%
Revenue Next 2Y9.58%
Revenue Next 3Y10.09%
Revenue Next 5Y8.86%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 32.36, which means the current valuation is very expensive for PGNY.
PGNY's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.76. PGNY is valued slightly more expensive when compared to this.
Based on the Price/Forward Earnings ratio of 18.47, the valuation of PGNY can be described as rather expensive.
Based on the Price/Forward Earnings ratio, PGNY is valued a bit cheaper than the industry average as 68.32% of the companies are valued more expensively.
PGNY's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.63.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.36 | ||
| Fwd PE | 18.47 |
4.2 Price Multiples
PGNY's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PGNY indicates a rather cheap valuation: PGNY is cheaper than 90.10% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.63 | ||
| EV/EBITDA | 14.4 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PGNY does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of PGNY may justify a higher PE ratio.
A more expensive valuation may be justified as PGNY's earnings are expected to grow with 31.82% in the coming years.
PEG (NY)3.02
PEG (5Y)N/A
EPS Next 2Y34.66%
EPS Next 3Y31.82%
5. Dividend
5.1 Amount
No dividends for PGNY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
19.09
-0.14 (-0.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.25%
Inst Owner Change0.39%
Ins Owners1.34%
Ins Owner Change0.04%
Market Cap1.64B
Revenue(TTM)1.24B
Net Income(TTM)53.12M
Analysts80
Price Target29.29 (53.43%)
Short Float %8.26%
Short Ratio5.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.43%
Min EPS beat(2)-11.77%
Max EPS beat(2)14.63%
EPS beat(4)2
Avg EPS beat(4)-0.31%
Min EPS beat(4)-19.12%
Max EPS beat(4)15%
EPS beat(8)5
Avg EPS beat(8)9.53%
EPS beat(12)9
Avg EPS beat(12)48.1%
EPS beat(16)13
Avg EPS beat(16)104.01%
Revenue beat(2)2
Avg Revenue beat(2)2.57%
Min Revenue beat(2)1.96%
Max Revenue beat(2)3.19%
Revenue beat(4)3
Avg Revenue beat(4)1.39%
Min Revenue beat(4)-5.35%
Max Revenue beat(4)5.74%
Revenue beat(8)4
Avg Revenue beat(8)-0.57%
Revenue beat(12)7
Avg Revenue beat(12)0.46%
Revenue beat(16)8
Avg Revenue beat(16)-0.53%
PT rev (1m)0%
PT rev (3m)7.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.39%
EPS NY rev (1m)0%
EPS NY rev (3m)13.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.35%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.36 | ||
| Fwd PE | 18.47 | ||
| P/S | 1.32 | ||
| P/FCF | 8.63 | ||
| P/OCF | 8.13 | ||
| P/B | 3.19 | ||
| P/tB | 3.36 | ||
| EV/EBITDA | 14.4 |
EPS(TTM)0.59
EY3.09%
EPS(NY)1.03
Fwd EY5.41%
FCF(TTM)2.21
FCFY11.59%
OCF(TTM)2.35
OCFY12.31%
SpS14.44
BVpS5.99
TBVpS5.68
PEG (NY)3.02
PEG (5Y)N/A
Graham Number8.92
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.98% | ||
| ROE | 10.31% | ||
| ROCE | 14.2% | ||
| ROIC | 10.87% | ||
| ROICexc | 24.96% | ||
| ROICexgc | 28.14% | ||
| OM | 6.18% | ||
| PM (TTM) | 4.28% | ||
| GM | 22.34% | ||
| FCFM | 15.31% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
ROICexc(3y)19.18%
ROICexc(5y)17.15%
ROICexgc(3y)20.6%
ROICexgc(5y)18.86%
ROCE(3y)10.79%
ROCE(5y)10.01%
ROICexgc growth 3Y11.16%
ROICexgc growth 5Y-10.91%
ROICexc growth 3Y11.54%
ROICexc growth 5Y-2.19%
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
F-Score8
Asset Turnover1.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 293.7% | ||
| Cap/Sales | 0.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 250.02% | ||
| Profit Quality | 358.02% | ||
| Current Ratio | 2.7 | ||
| Quick Ratio | 2.7 | ||
| Altman-Z | 6.88 |
F-Score8
WACC9.15%
ROIC/WACC1.19
Cap/Depr(3y)177.5%
Cap/Depr(5y)150.16%
Cap/Sales(3y)0.4%
Cap/Sales(5y)0.39%
Profit Quality(3y)290.66%
Profit Quality(5y)196.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.35%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%11.76%
EPS Next Y10.72%
EPS Next 2Y34.66%
EPS Next 3Y31.82%
EPS Next 5Y32.47%
Revenue 1Y (TTM)9.62%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.47%
Revenue Next Year9.74%
Revenue Next 2Y9.58%
Revenue Next 3Y10.09%
Revenue Next 5Y8.86%
EBIT growth 1Y7.81%
EBIT growth 3Y27.82%
EBIT growth 5Y41.01%
EBIT Next Year33.19%
EBIT Next 3Y18.12%
EBIT Next 5Y15.38%
FCF growth 1Y14.92%
FCF growth 3Y93.67%
FCF growth 5YN/A
OCF growth 1Y19.24%
OCF growth 3Y90.18%
OCF growth 5YN/A
PROGYNY INC / PGNY FAQ
What is the fundamental rating for PGNY stock?
ChartMill assigns a fundamental rating of 6 / 10 to PGNY.
What is the valuation status for PGNY stock?
ChartMill assigns a valuation rating of 4 / 10 to PROGYNY INC (PGNY). This can be considered as Fairly Valued.
How profitable is PROGYNY INC (PGNY) stock?
PROGYNY INC (PGNY) has a profitability rating of 7 / 10.
What are the PE and PB ratios of PROGYNY INC (PGNY) stock?
The Price/Earnings (PE) ratio for PROGYNY INC (PGNY) is 32.36 and the Price/Book (PB) ratio is 3.19.
Can you provide the expected EPS growth for PGNY stock?
The Earnings per Share (EPS) of PROGYNY INC (PGNY) is expected to grow by 10.72% in the next year.